Tissue damage and functional abnormalities in organs have become a considerable clinical
challenge. Organoids are often applied as disease models and in drug discovery and …

Personalized medicine aims to provide tailored medical treatment that considers the clinical,
genetic, and environmental characteristics of patients. iPSCs have attracted considerable …

Definitive treatment of dry eye disease (DED), one of the commonest ocular surface
disorders, has remained elusive despite several recent advances in better diagnostics and …

Dental pulp stem cells (DPSC) are a relatively new alternative stem cell source for the study
of neurogenetic disorders. DPSC can be obtained non-invasively and collected from long …

Induced pluripotent stem cells (iPSCs) are adult somatic cells genetically reprogrammed to
an embryonic stem cell‐like state. Notwithstanding their autologous origin and their potential …

Ocular surface inflammatory disorders (OSIDs) are a group of highly prevalent,
heterogeneous diseases that display a variety of aetiologies and symptoms and are risk …

Background Stem cell‐based therapy (SCT) is an important component of regenerative
therapy that brings hope to many patients. After decades of development, SCT has made …

As human-origin cells, human dental pulp stem cells (hDPSCs) are thought to be potentially
useful for biological and medical experiments. They are easily obtained from lost primary …

Organoids are 3D structures generated from stem cells. Their functions and physiological
characteristics are similar to those of normal organs. They are used in disease mechanism …

The derivation of gametes from patient-specific pluripotent stem cells may provide new
perspectives for genetic parenthood for patients currently facing sterility. We use current data …